FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for prediction of risk of recurrent thyroid cancer after radical surgical intervention. Six months after thyroidectomy, the blood serum is examined for the expression level of siRNA-221. If value exceeds 0.37, a high risk of developing recurrence of the disease in the next two years after thyroidectomy is predicted.
EFFECT: method enables predicting the risk of recurrent thyroid cancer in the next two years after thyroidectomy by measuring the level of siRNA-221 expression in blood serum 6 months after the radical surgical intervention.
1 cl, 3 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RECURRENT THYROID CANCER AFTER RADICAL SURGERY | 2024 |
|
RU2823255C1 |
| METHOD FOR DIAGNOSING MALIGNANT NEOPLASMS OF THYROID GLAND | 2023 |
|
RU2820815C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF NODULAR FORMATIONS OF THE HUMAN THYROID GLAND | 2021 |
|
RU2757347C1 |
| METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 |
|
RU2749361C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF THYROID NEOPLASMS | 2019 |
|
RU2705110C1 |
| METHOD FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULAR FORMATIONS OF THE THYROID GLAND | 2021 |
|
RU2783304C1 |
| METHOD FOR COMPLEX PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULES OF THE THYROID GLAND | 2022 |
|
RU2805941C1 |
| METHOD FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF ANAPLASTIC THYROID CANCER | 2021 |
|
RU2759128C1 |
| METHOD FOR PREOPERATIVE DETERMINATION OF VOLUME OF SURGICAL TREATMENT OF HIGH-DIFFERENTIATED THYROID CANCER | 2018 |
|
RU2709140C1 |
| METHOD FOR DETERMINING THERAPEUTIC APPROACH TO DIFFERENTIATED THYROID CARCINOMA COMBINED WITH HASHIMOTO'S THYROIDITIS WITH JUNCTION | 2013 |
|
RU2522388C1 |
